Improving genetic education and testing for Black cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance genetic education and increase requests for genetic testing among Black cancer survivors through a chatbot intervention compared to enhanced usual care. Participants will be randomly assigned to either the chatbot group or the usual care group, with the study evaluating engagement levels and psychosocial outcomes. The research will involve 428 Black cancer survivors who meet specific genetic testing criteria, focusing on their experiences and decision-making processes regarding genetic testing. The study seeks to address disparities in genetic testing utilization within this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18-80 years of age
* Self-identify as Black or African American
* At least 6-months post diagnosis with any of the following cancers: breast, ovarian, uterine, prostate, colorectal, pancreatic
* Have not had genetic testing for hereditary cancer
* Have received care at one of the participating sites in the prior five years
* Meet National Comprehensive Cancer Network criteria for germline GT
* Able to read and speak in English
* Capable of providing informed consent
* Have internet access (via smartphone, tablet or computer)
* Comfortable using a computer or mobile phone independently to access information

Exclusion Criteria:

* Do not speak English
* Unable to access the Internet
* Have previously undergone germline genetic testing for hereditary cancer risk or previously had genetic counseling (GC) and declined genetic testing (GT)
* Are unable to provide informed consent

Where it's running

• Georgetown Lombardi Comprehensive Cancer Center
  Washington D.C., District of Columbia, United States Recruiting
• Rutgers Cancer Institute
  New Brunswick, New Jersey, United States Recruiting

Study contacts

• Principal investigator: Anita Y Kinney, PhD, RN — Director at Rutgers Cancer Institute
• Study coordinator: Erin Speiser, PhD, MA
• Email: erin.speiser@rutgers.edu
• Phone: 732-675-1668

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reach and Engagement of Genetic Education, Risk Assessment, and Testing Feasibility (GENET) for PDAC risk

  This study tests whether online education plus a phone call from PanCAN helps Black, Latino/a, and Medicaid-enrolled people in Massachusetts learn about genetic and multi-cancer early detection testing and decide about getting tested.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07787156

• Support for Just-In-Time Consent for Prenatal Screening

  This study tests a short set of information cards delivered on a phone to help pregnant people decide about prenatal screening.

  Recruiting at 3 sites Case Western Reserve University · San Francisco, California and 2 other locations · NCT07557303

• Genetic testing for cancer risk in women visiting gynecology clinics

  This study is testing if offering genetic testing for cancer risk during gynecology visits is helpful and accepted by women aged 25-39.

  Recruiting NYU Langone Health · New York, New York · NCT06926816

• Understanding the immune response in Lynch syndrome patients

  This study is trying to see if certain antibodies in the immune system can help spot early signs of cancer in people with Lynch syndrome.

  Recruiting at 5 sites San Raffaele University · Monrovia, California and 4 other locations · NCT06708429

• Comparing direct and indirect methods for screening family members at risk for genetic conditions

  This study is testing two ways to reach out to family members at risk for Long QT Syndrome and Familial Hypercholesterolemia to see which method helps them get screened better, while also offering free genetic testing and counseling.

  Recruiting University of Maryland, Baltimore · Lancaster, Pennsylvania · NCT05348564

• Understanding how women with BRCA1/2 mutations respond to genetic risk testing

  This study looks at how women with BRCA1/2 mutations feel about genetic risk testing and how it affects their healthcare choices.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Boston, Massachusetts and 6 other locations · NCT03396341

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.